West Pharmaceutical Services Inc (WST)

NYSE
Currency in USD
217.95
-0.11(-0.05%)
Closed·
After Hours
217.950.00(0.00%)
·
WST Scorecard
Full Analysis
Management has been aggressively buying back shares
WST is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
216.30220.66
52 wk Range
187.43352.33
Key Statistics
Edit
Prev. Close
218.06
Open
217.89
Day's Range
216.3-220.66
52 wk Range
187.43-352.33
Volume
598.3K
Average Vol. (3m)
819.1K
1-Year Change
-32.33%
Book Value / Share
37.11
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
WST Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
281.92
Upside
+29.35%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 32 consecutive years
Show more

West Pharmaceutical Services Inc Company Profile

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

West Pharmaceutical Services Inc Earnings Call Summary for Q1/2025

  • West Pharmaceutical Q1 2025 EPS of $1.45 beat $1.23 forecast; revenue of $698M exceeded $684.94M expectation
  • Despite strong results, stock declined 3.79% pre-market; company maintains 'GOOD' financial health score
  • Full-year 2025 guidance: net sales $2.945B-$2.975B, organic growth 2-3%, adjusted EPS $6.15-$6.35
  • CEO highlights focus on returns, confidence in GLP-1 market; strategic shift towards drug handling services
  • Leadership changes and $20-$25M tariff impact pose potential risks; company expects high-value product growth
Last Updated: 04/24/2025, 10:32 AM
Read Full Transcript

Compare WST to Peers and Sector

Metrics to compare
WST
Peers
Sector
Relationship
P/E Ratio
33.5x20.1x−0.5x
PEG Ratio
−2.10−0.320.00
Price / Book
5.8x3.0x2.6x
Price / LTM Sales
5.4x1.7x3.0x
Upside (Analyst Target)
28.5%17.9%51.5%
Fair Value Upside
Unlock19.7%9.4%Unlock

Analyst Ratings

12 Buy
1 Hold
0 Sell
Ratings:
13 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 281.92
(+29.35% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.42%
Dividend Yield
0.39%
Industry Median 0.75%
Annualized Payout
0.84
Paid quarterly
5-Years Growth
+5.75%
Growth Streak

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
1.45 / 1.23
Revenue / Forecast
698.00M / 684.94M
EPS Revisions
Last 90 days

WST Income Statement

People Also Watch

307.20
UNH
-0.54%
160.00
STZ
-0.35%
90.72
PCAR
-0.42%
30.16
HRL
+0.33%
260.22
ECL
-0.43%

FAQ

What Is the West Pharmaceutical Services (WST) Stock Price Today?

The West Pharmaceutical Services stock price today is 217.95

What Stock Exchange Does West Pharmaceutical Services Trade On?

West Pharmaceutical Services is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for West Pharmaceutical Services?

The stock symbol for West Pharmaceutical Services is "WST."

Does West Pharmaceutical Services Pay Dividends? What’s The Current Dividend Yield?

The West Pharmaceutical Services dividend yield is 0.39%.

What Is the West Pharmaceutical Services Market Cap?

As of today, West Pharmaceutical Services market cap is 15.66B.

What Is West Pharmaceutical Services's Earnings Per Share (TTM)?

The West Pharmaceutical Services EPS (TTM) is 6.42.

When Is the Next West Pharmaceutical Services Earnings Date?

West Pharmaceutical Services will release its next earnings report on Jul 24, 2025.

From a Technical Analysis Perspective, Is WST a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has West Pharmaceutical Services Stock Split?

West Pharmaceutical Services has split 4 times.

How Many Employees Does West Pharmaceutical Services Have?

West Pharmaceutical Services has 10600 employees.

What is the current trading status of West Pharmaceutical Services (WST)?

As of Jun 20, 2025, West Pharmaceutical Services (WST) is trading at a price of 217.95, with a previous close of 218.06. The stock has fluctuated within a day range of 216.30 to 220.66, while its 52-week range spans from 187.43 to 352.33.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.